QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
44.96 ^USD	+1.77%		+5.34%	-39.00%

May. 15	QuidelOrtho Opens New Distribution Center in Pedricktown, NJ	CI
May. 14	Activist Jana Partners built position in QuidelOrtho in first quarter, sources say	RE

QuidelOrtho Corporation Provides Earnings Guidance for the Fiscal Year 2024

February 13, 2024 at 04:05 pm EST

QuidelOrtho Corporation provided earnings guidance for the fiscal year 2024. For the period, the company expects total revenues to be in the range of $2.76 billion to $3.07 billion.

Latest news about QuidelOrtho Corporation

QuidelOrtho Opens New Distribution Center in Pedricktown, NJ	May. 15	CI
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say	May. 14	RE
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	May. 14	MT
Jana Partners Acquires Stake in QuidelOrtho	May. 14	MT
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say	May. 14	RE
RBC Cuts Price Target on QuidelOrtho to $68 From $81, Keeps Outperform Rating	May. 09	MT
Transcript : QuidelOrtho Corporation, Q1 2024 Earnings Call, May 08, 2024	May. 08
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Posts Q1 Revenue $711M, vs. Street Est of $695.1M	May. 08	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q1 EPS $0.44, vs. Street Est of $0.40	May. 08	MT
QuidelOrtho Corporation Suspends Earnings Guidance for the Year 2024	May. 08	CI
QuidelOrtho Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
QuidelOrtho Corporation Announces CEO Changes	May. 02	CI
QuidelOrtho Corporation Appoints Brian J. Blaser as President and to the Board	May. 02	CI
QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	Apr. 02	MT
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	Apr. 02	MT
QuidelOrtho Corporation Receives FDA 510(K) Clearance for its QuickVue COVID-19 Test	Apr. 02	CI
QuidelOrtho Receives Canada's Approval for Triage PLGF Test to Detect Pregnancy Complications	Mar. 06	MT
Transcript : QuidelOrtho Corporation Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 04:00 PM	Mar. 05
Sector Update: Health Care Stocks Mixed Late Afternoon	Mar. 04	MT
Sector Update: Health Care	Mar. 04	MT
QuidelOrtho Shares Decline Following UBS Downgrade	Mar. 04	MT
UBS Downgrades QuidelOrtho to Sell From Neutral, Adjusts Price Target to $42 From $70	Mar. 04	MT
Sector Update: Health Care Stocks Mixed in Late Afternoon	Feb. 21	MT
Sector Update: Health Care	Feb. 21	MT
QuidelOrtho Terminates CEO Douglas Bryant, Postpones Investor Day	Feb. 21	MT

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-31 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for QuidelOrtho Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

44.96 USD

Average target price

51.4 USD

Spread / Average Target

+14.32%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
QUIDELORTHO CORPORATION	-39.00%	3.01B
SARTORIUS AG	-16.27%	19.69B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+22.02%	1.94B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.62%	1.66B
BIOTAGE AB	+35.83%	1.34B
CONTEC MEDICAL SYSTEMS CO.,LTD	-22.01%	895M
REVENIO GROUP OYJ	+6.33%	827M
VAREX IMAGING CORPORATION	-23.80%	638M
CELLAVISION AB	+10.38%	516M
PHC CO.,LTD.	-.--%	486M

Medical Diagnostic & Testing Equipment